IRIS - Res&Arch Institutional Research Information System - Research & Archive

FALINI, Brunangelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.522
EU - Europa 8.725
AS - Asia 7.800
SA - Sud America 1.350
Continente sconosciuto - Info sul continente non disponibili 930
AF - Africa 206
OC - Oceania 12
Totale 32.545
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.039
SG - Singapore 3.635
IT - Italia 1.890
IE - Irlanda 1.344
UA - Ucraina 1.170
RU - Federazione Russa 1.066
BR - Brasile 1.027
CN - Cina 1.023
SE - Svezia 1.015
HK - Hong Kong 876
VN - Vietnam 848
DE - Germania 529
FI - Finlandia 458
FR - Francia 448
KR - Corea 361
GB - Regno Unito 316
CA - Canada 256
IN - India 163
BD - Bangladesh 156
TR - Turchia 138
AR - Argentina 108
IQ - Iraq 96
NL - Olanda 88
MX - Messico 84
UZ - Uzbekistan 71
PL - Polonia 66
JP - Giappone 63
AT - Austria 56
CO - Colombia 56
ZA - Sudafrica 53
CH - Svizzera 50
PK - Pakistan 47
ID - Indonesia 46
EC - Ecuador 45
BE - Belgio 44
VE - Venezuela 39
ES - Italia 37
CZ - Repubblica Ceca 33
PH - Filippine 33
SA - Arabia Saudita 33
CR - Costa Rica 32
MA - Marocco 30
LB - Libano 25
JO - Giordania 24
ET - Etiopia 21
EG - Egitto 19
MY - Malesia 18
PE - Perù 18
CL - Cile 17
GR - Grecia 17
JM - Giamaica 17
LT - Lituania 17
GT - Guatemala 16
BO - Bolivia 15
KE - Kenya 15
KZ - Kazakistan 15
AZ - Azerbaigian 13
NI - Nicaragua 13
OM - Oman 13
PY - Paraguay 13
AE - Emirati Arabi Uniti 12
HN - Honduras 12
IL - Israele 12
NP - Nepal 12
TT - Trinidad e Tobago 12
DZ - Algeria 11
TN - Tunisia 11
UY - Uruguay 11
CW - ???statistics.table.value.countryCode.CW??? 10
RO - Romania 10
SV - El Salvador 10
TH - Thailandia 10
PS - Palestinian Territory 9
PT - Portogallo 9
AL - Albania 8
EE - Estonia 8
EU - Europa 8
AU - Australia 7
HU - Ungheria 7
KG - Kirghizistan 7
PA - Panama 7
PR - Porto Rico 7
BG - Bulgaria 6
RS - Serbia 6
SC - Seychelles 6
SN - Senegal 6
SY - Repubblica araba siriana 6
AO - Angola 5
DO - Repubblica Dominicana 5
GE - Georgia 5
NZ - Nuova Zelanda 5
BY - Bielorussia 4
CI - Costa d'Avorio 4
LA - Repubblica Popolare Democratica del Laos 4
QA - Qatar 4
AM - Armenia 3
HR - Croazia 3
IR - Iran 3
LK - Sri Lanka 3
LV - Lettonia 3
Totale 31.565
Salva come PNG Salva come JPEG
Città #
Singapore 2.529
Chandler 1.507
San Jose 1.381
Dublin 1.343
Ashburn 1.078
Hong Kong 870
San Mateo 715
Perugia 682
Jacksonville 615
Boardman 507
Santa Clara 489
Dong Ket 465
Council Bluffs 432
Moscow 377
Seoul 359
Altamura 333
Princeton 305
Medford 302
Lauterbourg 289
Wilmington 249
Beijing 237
Lawrence 232
Los Angeles 205
Ann Arbor 202
Andover 197
New York 191
Munich 167
Dallas 143
Ho Chi Minh City 135
Piscataway 133
The Dalles 127
Helsinki 124
Des Moines 101
São Paulo 95
Hanoi 87
Saint Petersburg 85
Turku 80
Rome 78
Shanghai 70
Norwalk 67
Orem 62
Montreal 60
Izmir 59
Tokyo 56
Houston 53
Frankfurt am Main 51
Brooklyn 49
Chicago 49
Woodbridge 49
Falls Church 47
London 47
Milan 46
Toronto 46
Phoenix 45
North Bergen 44
Nuremberg 43
Amsterdam 42
Brussels 42
Baghdad 41
San Paolo di Civitate 41
Atlanta 39
Tashkent 38
Belo Horizonte 36
Denver 36
Chennai 35
Ottawa 35
Redmond 35
Johannesburg 34
Rio de Janeiro 33
San Francisco 33
Warsaw 32
Charlotte 31
Manchester 29
Mexico City 29
Redwood City 27
Stockholm 27
San José 25
Bologna 24
Boston 22
Haiphong 22
Foligno 21
Philadelphia 21
Amman 20
Naples 20
Addis Ababa 19
Ankara 19
Dearborn 19
Poplar 19
Guangzhou 18
Lahore 18
Brasília 17
Buffalo 17
Dhaka 17
Auburn Hills 16
Columbus 16
Curitiba 16
Medellín 16
Vienna 16
Barnet 15
Falkenstein 15
Totale 19.532
Salva come PNG Salva come JPEG
Nome #
BCOR gene alterations in hematological diseases 199
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 190
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice 190
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 179
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? 172
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) 171
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial 161
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biological and clinical features 160
NPM1 deletion is associated with gross chromosomal rearrangements in leukemia 159
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma 159
Anaplastic lymphoma kinase expression as a marker of malignancy. Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction. 157
Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy. 155
Acute leukaemia immunophenotyping in bone-marrow routine sections. 153
ARPIR: automatic RNA-Seq pipelines with interactive report 153
Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. 152
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 151
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 150
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. 148
ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS 147
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 145
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 143
Mutant NPM1 Maintains the Leukemic State through HOX Expression 142
Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification 140
Germline NPM1 mutations lead to altered rRNA 2′-O-methylation and cause dyskeratosis congenita 140
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma 139
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives. 138
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 137
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 137
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 136
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features 136
[The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics] 134
Choroidal vasculature analysis in MEK inhibitor-associated retinopathy 134
A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma. 133
"Designed" grafts for HLA-haploidentical stem cell transplantation. 133
L’esclusione degli anziani dai trial clinici in corso sul trattamento delle neoplasie ematologiche 131
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: Final results of the GIMEMA LAL 0904 study 130
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells 129
Genomics of Hairy cell leukemia 128
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 128
Anaplastic large cell lymphoma: pathological, molecular and clinical features. 127
EML4-ALK rearrangement in non-small-cell lung cancer and non-tumor lung tissues. 127
Acute Myeloid Leukemia with mutated nucleophosmin (NPM1). Any hope for a targeted therapy? 127
CD123 (IL-3R alpha) IS CONSISTENTLY EXPRESSED ON ACUTE MYELOID LEUKEMIA (AML) CARRYING NUCLEOPHOSMIN (NPM1) GENE MUTATION 127
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease 126
Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance 126
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 126
THE BRAF-MEK-ERK PATHWAY IN HAIRY CELL LEUKEMIA: A COMPREHENSIVE DISSECTION IN PRIMARY LEUKEMIC CELLS OF ITS BIOLOGICAL AND THERAPEUTIC RELEVANCE 126
Dactinomycin in NPM1-Mutated Acute Myeloid Leukemia 126
Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif. 125
IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. 125
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 125
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 124
Antigen retrieval techniques in immunohistochemistry: comparison of different methods 124
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 123
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 121
The EML4-ALK transcript but not the fusion protein can be expressed in reactive and neoplastic lymphoid tissues. 121
Bcl-6 protein expression in normal and neoplastic lymphoid tissues. 121
Aberrant hypermutation of PIM1, PAX5, RhoH/TTF and cMYC in nodular lymphocyte predominance Hodgkin's disease 120
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 120
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 120
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 119
Aggressive lymphomas: a convenient concept or an anatomo-pathological reality? 119
Clustering of genomic breakpoints at the MLL locus in therapy-related acute leukemia with t(4;11)(q21;q23). 119
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML 119
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia 118
Cellular localization and tissue distribution of PML proteins as defined by a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product. Preferential expression in postmitotic cells. 118
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 117
T regulatory cell separation for clinical application. 117
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients 117
Nucleophosmin regulates the stability and transcriptional activity of p53. 116
Minimal residual disease levels assessed by NPM1 mutation specific RQ-PCR provide important prognostic information in AML. 116
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 116
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 116
BRAF mutations in hairy-cell leukemia. 115
A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice. 115
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). 115
Fludarabine Plus Mitoxantrone With and Without Rituximab Versus CHOP With and Without Rituximab As Front-Line Treatment for Patients With Follicular Lymphoma. 114
Constant Activation of the RAF-MEK-ERK Pathway As a Diagnostic and Therapeutic Target in Hairy Cell Leukemia. 114
Primay large B-cell lymphoma (PLBCL) of the retroperitoneum: a heterogeneous group of neoplasms, some of which mimic PLBCL of the mediastinum. 113
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 113
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 113
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 113
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy 113
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis 112
Gene expression analysis of peripheral T-cell lymphoma not otherwise specified reveals the existance of two subgroups related to different cellular counterparts. 112
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin 112
Biological and therapeutic relevance of the BRAF-MEK-ERK pathway in hairy cell leukemia 112
BRAF V600E mutation in hairy cell leukemia: From bench to bedside 112
Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas 111
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity 111
MONOCLONAL ANTIBODIES PG-B6a AND PG-B6p RECOGNIZE, RESPECTIVELY, A HIGHLY CONSERVED AND A FORMOL-RESISTANT EPITOPE ON THE HUMAN BCL-6 PROTEIN AMINO-TERMINAL REGION. 110
Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma. 110
Richter's transformation in the heart 110
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. 109
A case of concomitant chronic lymphocytic leukaemia and hairy cell leukaemia evaluated for IGHV-D-J rearrangements and BRAF-V600E mutation: lack of evidence for a common origin 109
Current status and future perspectives in targeted therapy of NPM1-mutated AML 108
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray 108
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia 108
How I treat refractory/relapsed hairy cell leukemia with BRAF inhibitors 108
Functions of the native NPM1 protein and its leukemic mutant 107
Totale 12.960
Salva come PNG Salva come JPEG
Categoria #
all - tutte 147.848
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.848
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.263 0 0 0 184 109 41 30 785 71 161 452 430
2022/20234.805 333 868 48 405 388 537 6 220 1.716 62 165 57
2023/20241.763 128 194 102 48 18 20 406 30 151 53 303 310
2024/20254.551 132 477 182 148 610 182 239 396 930 249 624 382
2025/20269.936 812 599 416 1.118 1.345 930 1.642 555 1.234 892 275 118
2026/20273.064 240 354 603 1.867 0 0 0 0 0 0 0 0
Totale 32.545